JP2002535956A5 - - Google Patents

Download PDF

Info

Publication number
JP2002535956A5
JP2002535956A5 JP2000549770A JP2000549770A JP2002535956A5 JP 2002535956 A5 JP2002535956 A5 JP 2002535956A5 JP 2000549770 A JP2000549770 A JP 2000549770A JP 2000549770 A JP2000549770 A JP 2000549770A JP 2002535956 A5 JP2002535956 A5 JP 2002535956A5
Authority
JP
Japan
Prior art keywords
polypeptide
nucleic acid
acid molecule
isolated
functional part
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000549770A
Other languages
English (en)
Other versions
JP2002535956A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/011066 external-priority patent/WO1999060164A1/en
Publication of JP2002535956A publication Critical patent/JP2002535956A/ja
Publication of JP2002535956A5 publication Critical patent/JP2002535956A5/ja
Pending legal-status Critical Current

Links

Description

【特許請求の範囲】
【請求項１】 タンパク質608をコードする配列番号３２またはその機能的部分を有する単離された核酸分子、またはそれに少なくとも実質的に相同または同一であり同じ機能を有するポリペプチドをコードする核酸分子。
【請求項２】 ヒトタンパク質608またはその機能的部分をコードすることを特徴とする請求項１記載の単離された核酸分子。
【請求項３】 請求項１または２記載の単離された核酸分子を含むことを特徴とするベクター。
【請求項４】 請求項３記載のベクターを含むことを特徴とする組成物。
【請求項５】 請求項１または２記載の単離された核酸分子に特異的にハイブリダイズすることを特徴とするプローブまたはプライマー。
【請求項６】 請求項１または２記載の単離された核酸分子の発現産物。
【請求項７】 配列番号３３を有する単離されたタンパク質608ポリペプチドまたはその機能的部分、またはそれに少なくとも実施的に相同または同一であり同じ機能を有するポリペプチド。
【請求項８】 ヒトタンパク質608またはその機能的部分を有することを特徴とする請求項７記載の単離されたポリペプチド。
【請求項９】 請求項７または８記載のポリペプチドまたはその機能的部分により誘発されることを特徴とする抗体。
【請求項１０】 請求項７または８記載の単離されたポリペプチド、または請求項９記載の抗体またはその機能的部分を含むことを特徴とする組成物。
JP2000549770A 1998-05-15 1999-05-14 物理的ストレスにより誘発される遺伝子、その発現産物およびその使用方法 Pending JP2002535956A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8567398P 1998-05-15 1998-05-15
US60/085,673 1998-05-15
PCT/US1999/011066 WO1999060164A1 (en) 1998-05-15 1999-05-14 Mechanical stress induced genes, expression products therefrom, and uses thereof

Publications (2)

Publication Number Publication Date
JP2002535956A JP2002535956A (ja) 2002-10-29
JP2002535956A5 true JP2002535956A5 (ja) 2006-07-06

Family

ID=22193209

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000549770A Pending JP2002535956A (ja) 1998-05-15 1999-05-14 物理的ストレスにより誘発される遺伝子、その発現産物およびその使用方法

Country Status (9)

Country Link
EP (1) EP1082463B1 (ja)
JP (1) JP2002535956A (ja)
AT (1) ATE350486T1 (ja)
AU (1) AU4004699A (ja)
CA (1) CA2332150A1 (ja)
DE (1) DE69934688T2 (ja)
IL (2) IL139637A0 (ja)
WO (1) WO1999060164A1 (ja)
ZA (1) ZA200006613B (ja)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151514A1 (en) * 1998-05-11 2002-10-17 Paz Einat Genes associated with mechanical stress, expression products therefrom, and uses thereof
US7259253B2 (en) 1999-05-14 2007-08-21 Quark Biotech, Inc. Genes associated with mechanical stress, expression products therefrom, and uses thereof
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2001025488A2 (en) * 1999-10-06 2001-04-12 Quark Biotech, Inc. Method for enrichment of natural antisense messenger rna
US6986988B2 (en) 1999-10-06 2006-01-17 Quark Biotech, Inc. Method for enrichment of natural antisense messenger RNA
US6468749B1 (en) 2000-03-30 2002-10-22 Quark Biotech, Inc. Sequence-dependent gene sorting techniques
AU2002221046A1 (en) * 2000-12-06 2002-06-18 Takara Shuzo Co., Ltd. Functional dna array
CA2441936A1 (en) 2001-03-23 2002-10-03 Yoshihiro Nakatani Methods and compositions for modulating tumor suppression
US20030191073A1 (en) 2001-11-07 2003-10-09 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
BE1014949A3 (fr) * 2001-08-14 2004-07-06 Probiox Procede de detection de stress oxydant et trousse pour sa mise en oeuvre.
AU2002361610B2 (en) 2001-11-07 2007-01-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
MXPA05013115A (es) * 2003-06-06 2006-05-25 Wyeth Corp Metodos y materiales para identificar agentes que modulan la remodelacion de hueso y agentes identificados por los mismos.
AU2005291862B2 (en) 2004-10-08 2010-07-08 Clinuvel Pharmaceuticals Limited Compositions and methods for inducing melanogenesis in a subject
EP2444099A1 (en) 2005-03-31 2012-04-25 Agensys, Inc. Antibodies and related molecules that bind to 161P2F10B proteins
US8350009B2 (en) 2005-03-31 2013-01-08 Agensys, Inc. Antibodies and related molecules that bind to 161P2F10B proteins
JP2009512421A (ja) 2005-08-15 2009-03-26 ヴァクシン インコーポレイテッド 非複製性ベクターワクチン投与による鳥類への免疫方法
FR2893328B1 (fr) * 2005-11-17 2014-01-31 Lvmh Rech Procede pour depister des marqueurs impliques dans la resistance de keratinocytes a des deformations mecaniques.
US8334265B2 (en) 2006-08-31 2012-12-18 Clinuvel Pharmaceuticals Limited Method of treatment of photodermatoses
HUE038611T2 (hu) 2008-03-27 2018-10-29 Clinuvel Pharmaceuticals Ltd Vitiligo terápia
BR112012019780A2 (pt) 2010-02-08 2020-09-01 Agensys, Inc. conjugados de fármaco e anticorpo (adc) que ligam a proteínas 161p2f10b
EP2487185A1 (en) 2011-02-11 2012-08-15 Clinuvel Pharmaceuticals Limited Hexapeptide with improved activity in the repair of cellular DNA of dermal cells
EP3205353B1 (en) 2011-03-21 2021-01-13 Altimmune Inc. Rapid and prolonged immunologic-therapeutic
SI2741740T1 (sl) 2011-08-12 2017-08-31 Merial, Inc. Vakuumsko konzerviranje bioloških proizvodov, zlasti cepiv
WO2014012090A1 (en) 2012-07-13 2014-01-16 The Broad Institute, Inc. Molecular sleds comprising a positively-charged amino acid sequence and a molecular cargo and uses thereof
CN116622704A (zh) 2012-07-25 2023-08-22 布罗德研究所有限公司 可诱导的dna结合蛋白和基因组干扰工具及其应用
WO2014121104A1 (en) * 2013-01-31 2014-08-07 The Regents Of The University Of California Pooled genetic perturbation effects
US11332719B2 (en) 2013-03-15 2022-05-17 The Broad Institute, Inc. Recombinant virus and preparations thereof
WO2015057671A1 (en) 2013-10-14 2015-04-23 The Broad Institute, Inc. Artificial transcription factors comprising a sliding domain and uses thereof
JP6545084B2 (ja) * 2015-11-11 2019-07-17 株式会社Adeka 潤滑油組成物及びその製造方法
WO2022198126A1 (en) * 2021-03-19 2022-09-22 Washington University Methods for generating mechanically-responsive cells and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9204303A (es) * 1991-07-23 1993-11-01 Rhone Poulenc Rorer Int Factor regulador del crecimiento de osteoclasto.
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
US5763416A (en) * 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5968770A (en) * 1995-02-10 1999-10-19 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
US5861249A (en) * 1996-04-23 1999-01-19 Cold Spring Harbor Laboratory Assays and reagents for identifying modulators of cdc25-mediated mitotic activation

Similar Documents

Publication Publication Date Title
JP2002535956A5 (ja)
WO2007002261A3 (en) IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF
WO2001079462A3 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
EP1005540A4 (en) IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS
WO2001072976A3 (en) 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor
WO2001079463A3 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
WO2003020932A1 (fr) Nouvelles proteines de secretion et adn associe
WO1996015144A3 (en) Chromosome 21 gene marker, compositions and methods using same
WO2004035618A3 (en) Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
WO2002010336A3 (en) Mutacin i biosynthesis genes and proteins
WO2003031594A3 (en) Nucleotide and amino acid sequences relating to respiratory diseases and obesity
WO2009083968A8 (en) Novel protein
WO2002074960A3 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
MXPA01004353A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
WO2001070808A3 (en) Angiogenesis - associated proteins, and nucleic acids encoding the same
WO2002002771A3 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
WO2001036478A3 (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
WO2001000662A3 (en) The use of human fgh-8 polypeptides as neurotrophic agents
WO2001083552A3 (en) Human sez6 nucleic acids and polypeptides
WO2000026237A3 (en) Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof
JP2004518410A5 (ja)
EP0897984A3 (en) D-Sorbitol dehydrogenase gene
WO2000037492A3 (en) Human hepatoma-derived growth factor homologous (huhdgfh) ____
WO2002000863A3 (en) 32140, a novel human aldehyde dehydrogenase and uses therefor
WO2000029586A3 (en) Maize dna ligase i orthologue and uses thereof